the therapeutic function of EPCs have asserted that EPCs perform a critical role in neovascularization under pathological as well as physiological conditions. Under pathological conditions, in particular, circulating EPCs converge at the damaged site and recover lesions via a variety of processes, including differentiation, invasion, and release of growth factors (24, 28, 50) . There is interesting evidence suggesting that the transplantation of EPCs enhances in vivo postnatal neovasculogenesis and repairs infarcted myocardium (3, 18, 19, 28, 38) . Furthermore, the numerical and functional changes in EPCs obtained from patients may be put forth as a criterion for the diagnosis of vascular disease (20, 21, 34, 38) .
EPCs can be obtained from bone marrow, peripheral blood, and umbilical cord blood and can be sequentially divided into "early" EPCs and "late" EPCs. In particular, it has been demonstrated that EPCs derived from umbilical cord blood have more advantages than those from other sources (17, 28) and that, unlike early EPCs, since late EPCs express a variety of endothelial markers and functionally differentiate into mature endothelial cells, late EPCs are widely used for study in the field of vascular biology (50) .
Ion channels are accountable for a variety of physiological events, and their dysfunction leads to several diseases by the disruption of balance of cells, tissues, and organs. In recent years, with further developments in stem cell research, several ion channels have been identified and considered as novel modulators that control the differentiation and modulation of stem cells (4, 13, 31, 42) . The inward rectifier K ϩ channel (Kir), as one of the K ϩ channels, is important for the maintenance of the resting membrane potential (RMP). Kir is composed of seven families. Importantly, Kir2.x has an interesting property in which inward rectifying K ϩ conductance increases when the membrane potential is held below the equilibrium potential for K ϩ , by which RMP of cells is stably maintained. Also, some Kir subtypes, such as G protein-activated inward rectifier K ϩ channel (Kir3.x) and ATP-sensitive K ϩ (K ATP ) channel (Kir6.x), triggered by extracellular ligands and intracellular ATP, have been established to modulate a variety of cellular events and signaling cascades. Recently, many reports have suggested that voltage-dependent Kir expressed in neural stem cells determines electrical properties, which results in the increase of cell proliferation (49) , K ATP is associated with myelination and proliferation of oligodendrocyte precursor cells (40) , and the hyperpolarization of membrane potential induced through overexpression of Kir2.1 leads to the differentiation of human cardiomyocyte progenitor cells (46) . How-ever, despite many results about Kir in various stem cells, the expression and function of Kir on the membrane of EPCs are not yet understood. In the present study, we focused primarily on Kir and established its expression and physiological role in EPCs using a variety of experimental tools.
MATERIALS AND METHODS
Isolation and culture of EPCs. This study was approved by the Institutional Review Board of Seoul National University Hospital. Human umbilical cord blood-derived late EPCs were isolated and cultured as described previously (50) . In brief, human umbilical cord blood (50 ml) obtained with informed consent from donors was fractionated via centrifugation of the Ficoll-Plaque (GE Healthcare) gradient. According to the manufacturer's instructions, isolated mononuclear cells were resuspended using an EGM-2-MV system (catalog no. CC-3162; Clonetics) consisting of endothelial basal medium, 5% fetal bovine serum, hEGF, VEGF, hFGF-B, IGF-I, ascorbic acid, and heparin. Mononuclear cells (5 ϫ 10 6 per well) were seeded on 1.5% fibronectin-coated (Sigma, St. Louis, MO) six-well plates and incubated in a 5% CO2 incubator at 37°C. Under daily observation, the first media change was conducted within 6 days after plating. Thereafter, media were changed every 3 days. Late EPCs from mononuclear cells appeared within 2 wk after plating as colonies consisting of cells with different morphology from early EPCs.
Confirmation of EPC molecular phenotype. To confirm the EPC phenotype, adherent cells were incubated with DiI-labeled ac-LDL (Molecular Probes) for 1 h, fixed, and then incubated for 1 h with FITC-labeled VE-cadherin antibody (BenderMed Systems). Cells were visualized using an inverted fluorescent microscope (Olympus IX71), and adherent cells staining positive for both FITC-VE-cadherin and DiI-ac-LDL were identified as EPCs. Fluorescence was excited at 488 nm and 530 nm, and emission was recorded at 530 nm and 620 nm, respectively. To evaluate the surface marker phenotype of the cultured EPC population, the cells were detached with trypsin-EDTA 0.25% and labeled for 30 min at 4°C at the concentrations recommended by the manufacturer with the following fluorescent antibodies: FITC-labeled CD34 (Becton-Dickinson), PE-labeled KDR (R&D Systems), VEGFR-3 (R&D Systems), ICAM-1 (R&D Systems), Tie-2 (R&D Systems), APC-labeled CD44 (eBioscience), PE-cy5-labeled integrin-␤1 (eBioscience), and integrin-␤2 (Santa Cruz Biotechnology). Fluorescent isotype-matched antibodies were utilized as negative controls. Cells were washed, fixed by paraformaldehyde (Wako), and analyzed on a FACS Canto II Instrument (Becton-Dickinson).
Electrophysiological recordings. Whole cell currents were measured using an EPC 8 amplifier (HEKA, Lambrecht, Germany) connected via an ITC-16 (Instrutech) to an IBM-compatible computer and filtered at 4 kHz. Patch pipettes were pulled from borosilicate glass capillaries (World Precision Instruments, Sarasota, FL) using a vertical pipette puller (Narishige PC-10). These pipettes had a resistance of 5-7 M⍀ filled with a solution containing (in mM) 140 KCl, 5 NaCl, 0.5 MgCl 2, 5 CaCl2,3 Mg-ATP, 10 EGTA, 10 HEPES, and 5 glucose. The pH was adjusted to 7.4 with KOH. The external solution containing (in mM) 145 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, and 5 glucose was used as a normal bath solution. The pH was adjusted to 7.4 with NaOH. Each pipette was generated for highresistance seals without fire polishing. For whole cell recording, a coverslip attached with EPCs was transferred into a chamber. After the G⍀ seal was made by attachment to the cell membrane and negative suction, the pipette capacitive currents were compensated. To establish the whole cell configuration, the cell membrane was ruptured by weak negative suction. We did not compensate for cell capacitance and series resistance in each cell. EPCs were held at Ϫ70 mV. A series of voltage steps from Ϫ140 to ϩ60 mV for 500 ms per pulse at an interpulse interval of 5 s were used to record the voltage-dependent currents. To maximize and isolate the inward potassium currents, the potassium concentration in the extracellular solution was increased to 140 mM by iso-osmotic substitution of NaCl for KCl. To minimize other currents, we inhibited the voltage-gated potassium channel, KATP channel, and Ca 2ϩ -dependent Cl Ϫ channel using tetraethylammonium (TEA, 1 mM), glibenclamide (10 M), and niflumic acid (100 M), respectively. Under these conditions, the holding potential of EPCs was changed to 0 mV. All recordings were conducted at room temperature. The acquired whole cell current was analyzed with the Pulse-Fit program (HEKA).
Measurement of changes in the membrane potential. The membrane potential of EPCs was assessed using the fluorescence indicator of membrane potential, DiBAC3 (Molecular Probes). EPCs on coverslips were transferred to a chamber adapted to a confocal laser-scanning fluorescence microscope (Olympus) and incubated for 20 min in external solution with 0.3 M DiBAC3 at room temperature. The fluorescence signal intensity was evaluated at 10-s intervals. Using 5, 60, and 140 mM KCl solutions with 0.3 M DiBAC3, we optimized the recording conditions in our experiment. To confirm the change in membrane potential in EPCs by blockage of Kir, we added 10 M Ba 2ϩ to block Kir and 140 mM KCl as experimental controls. Fluorescence was excited at 488 nm and emission was recorded at 530 nm.
Reverse transcription-polymerase chain reaction. Total mRNA was extracted from EPCs using TRIzol reagent (Invitrogen), according to the manufacturer's instructions. The first-strand cDNA was synthesized using the reverse-transcription system (Promega) and amplified by NOVA-Taq DNA polymerase (Genenmed) in a 25-l reaction mixture. Each cDNA was subjected to polymerase chain reaction (PCR) amplification using gene-specific primers and was sequenced by chain termination using an ABI PRIZM3100 genetic analyzer (Applied Biosystems). The primer sequences and PCR conditions for each of the Kir subtypes and the GADPH housekeeping gene are listed in Table 1 . Control reactions consisted of the above mentioned PCR amplification mix with primers but no cDNA template. PCR was conducted using a PCR system 3700 (Applied Biosystems). PCR cycles were programmed as follows: 94°C for 10 min, 35 cycles consisting of 30 s denaturation at 94°C, 30 s at the annealing temperature indicated in Table 1 , and 45 s extension at 72°C, with a final extension at 72°C for 5 min. The mRNA expression of GAPDH was used utilized as an internal control. The size of the PCR product was confirmed by running 10 l of product on 1.0% agarose gel electrophoresis and visualized via ethidium bromide staining. Commercially available human heart mRNA (Ambion) and water were used as positive and negative controls, respectively. Western blot analysis. To extract total protein from EPCs, EPCs were lysed with a buffer [25 mM Tris, pH 7.4, 10 mM NaCl, 1% Triton X-100, 1% cholic acid, and phosphatase inhibitor cocktail (PIC)]. Lysates were clarified via centrifugation at 7,300 g for 10 min at 4°C. Protein concentrations were then determined via a Bradford assay. The lysates (40 g) were solubilized in a loading buffer containing 250 mM Tri-Cl, pH 6.8, 357.7 mM ␤-mercaptoethanol, 10% SDS, 0.5% bromphenol blue, 50% glycerol, and PIC, boiled for 10 min, and separated via 10% SDS-polyacrylamide gel electrophoresis. The proteins were then transferred electrophoretically onto a polyvinylidene difluoride membrane. The membrane was blocked with phosphate-buffered saline (PBS) containing 0.05% Tween 20 and 2.5% skim milk for 1 h. After being blocked, the transferred membranes were incubated with rabbit polyclonal anti-Kir2.1 (Santa Cruz Biotechnology), goat polyclonal anti-Kir2.4 (Santa Cruz Biotechnology), rabbit polyclonal anti-Kir3.1 (Santa Cruz Biotechnology), goat polyclonal anti-Kir6.2 (Santa Cruz Biotechnology), and GAPDH (Santa Cruz Biotechnology) in PBS containing 0.05% Tween 20. After three washings with PBS, the membrane was reacted with the appropriate horseradish-peroxidase (HRP)-conjugated rabbit IgG as a secondary antibody (Santa Cruz Biotechnology) and HRPconjugated goat IgG as a secondary antibody (Santa Cruz Biotechnology). The membranes were then immunoblotted. The bands were visualized with SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL).
Immunofluorescence. EPCs were seeded onto a slide and fixed with 4% paraformaldehyde at pH 7.4. After being rinsed three times with PBS, EPCs were permeabilized with 0.1% Triton in PBS buffer for 2 min, blocked with 5% bovine serum albumin in physiological saline solution with 0.1% Triton for 10 min at room temperature, and exposed to rabbit polyclonal anti-Kir2.1 antibody (1:50 dilution; Santa Cruz Biotechnology) for 1 h at room temperature. After three washes with PBS containing 0.1% Triton X-100, EPCs were incubated with a secondary antibody conjugated to Alexa Fluor 488 goat antirabbit IgG (1:200 dilution; Molecular Probes) for 50 min in the dark at room temperature and treated with DAPI (Sigma) to stain the nuclei in the EPCs. After several additional washes, coverslips were mounted with Gel/Mount (Biomega). Immunofluorescent images were captured with a confocal fluorescence microscope (Zeiss LSM410). The excitation and emission wavelengths were 488 nm and 525 nm, respectively.
In vitro tube formation on Matrigel plate. Matrigel (BectonDickinson Labware) basement membrane matrix was added to a chamber slide. After 1 h of incubation at room temperature, 1 ϫ 10 5 EPCs/ml were added to the chamber slide with 100 l of EGM-2-MV media containing 0, 1, and 10 M Ba 2ϩ . After 16 -24 h of incubation, we randomly chose 10 representative fields from an unbiased examiner in each plate, and the averages of the total number and area of complete tubes formed by EPCs per unit area were compared by Image-Pro Plus.
Assessment of EPC number and cell cycle analysis. The number of EPCs was determined in EGM-2-MV including 0, 1, and 10 M BaCl 2. EPCs were detached on culture dishes using 0.25% trypsin-EDTA and counted with a hemocytometer (Reichert) under an in- verted microscope. To determine the percentages of G0/G1, S, and G2/M phase cells, detached EPCs were washed in PBS and fixed with 70 -100% ethanol. Ethanol was removed with a centrifuge, and the cell pellets were washed with PBS. EPCs were incubated with PBS including propidium iodide (Sigma) and analyzed using FACS. Data were acquired with Cell Quest software.
RNA interference. The small interfering RNAs (siRNAs) were transfected into EPCs at 50 -60% confluence using siRNA transfection reagent (Santa Cruz Biotechnology) for 6 h, and then transfection media were exchanged for EGM-2-MV. The efficiency of transfection was confirmed by a comparison of the expression of target protein in each group treated with negative universal control siRNA and target siRNA (Santa Cruz Biotechnology) 24 h after treatment. EPCs were detached on culture dishes using 0.25% trypsin-EDTA and counted with a hemocytometer (Reichert) under an inverted microscope, 2-3 days after transfection.
Data analysis. Data are expressed as means Ϯ SE. Statistical analyses were conducted using paired Student's t-test (ANOVA, independent). The differences between groups were considered significant at P Ͻ 0.05. Fig. 2 . Whole cell currents and inwardly rectifying K ϩ currents in EPCs. A: morphology of late EPCs seeded on a coverslip for whole cell patchclamp recording. Scale bar, 30 m. B: established voltage protocol used to measure whole cell currents. EPCs were changed from a holding potential of Ϫ70 mV to pulse potentials between Ϫ140 mV and ϩ60 mV for 500 ms. C: representative trace of currents that were recorded by the voltage protocol. D: current-voltage (I-V) relationship plotted from average currents recorded using step pulses from Ϫ140 to ϩ60 mV during 400 -500 ms, which shows two types of currents including inwardly rectifying currents and outwardly rectifying currents. E: representative trace of inward rectifying currents measured in each condition containing 5, 60, and 140 mM KCl with tetraethylammonium (TEA; 1 mM), glibenclamide (10 M), and niflumic acid (100 M) to inhibit the voltage-gated potassium channels, ATP-sensitive potassium channels, and Ca 2ϩ -dependent Cl Ϫ channels, respectively. F: I-V relationship plotted from average currents recorded using step pulses from Ϫ140 to ϩ60 mV during 400 -500 ms (5, 60, and 140 mM KCl) (n ϭ 17, 7, and 17, respectively). The capacitive current traces in C and E are truncated.
RESULTS

Characterization of human umbilical cord blood-derived
EPCs. Late EPCs appeared in cultured human umbilical cord blood mononuclear cells after 2-3 wk. The colonies evidenced characteristic homogeneity and "cobblestone" morphology on the third-fifth passages, as previously reported (Fig. 1A) (14, 50) . To further characterize cell outgrowth, in accordance with previous reports (15), we conducted several experiments. EPCs were identified as double-positive for DiI-Ac-LDL uptake (Fig.  1B) and VE-cadherin (Fig. 1C) under a fluorescence microscope. Additionally, we confirmed the expression of endothelial-specific markers: CD34, KDR/VEGFR-2, VEGF-3, ICAM-1, Tie-2, CD44, Ib-1, and Ib-2 via flow cytometry (Fig.  1D) . These results demonstrated that the late EPCs for recording electrophysiological properties are well isolated and identified.
Whole cell currents and the existence of inwardly rectifying K ϩ currents in EPCs. In the electrophysiology experiments, we used the third and fourth passage EPCs that appeared at 28 Ϯ 3 days. The whole cell configuration was made to record currents through membrane channels in EPCs (Fig. 2A) . The membrane capacitance was 29.8 Ϯ 1.8 pF (n ϭ 27). The RMP was Ϫ49.6 Ϯ 6.8 mV (n ϭ 8), which was measured via the previously recorded calibration procedure (36) . Whole cell membrane currents of EPCs were recorded with 500-ms voltage steps between Ϫ140 mV and ϩ60 mV from a holding potential of Ϫ70 mV. The majority of EPCs that we recorded showed electrophysiological homogeneity, which supports our previous notion that the population of late EPCs is homogenous in vitro (14) . Figure 2D demonstrates that inwardly rectifying currents were induced at hyperpolarized membrane potentials. To prove whether these inwardly rectifying currents are dependent on the extracellular potassium concentration, we established experimental conditions in which inward rectifying currents could be isolated by using TEA (1 mM), glibenclamide (10 M), and niflumic acid (100 M) to inhibit voltagegated K ϩ channels, K ATP channels, and Ca 2ϩ -dependent Cl Ϫ channels, respectively. As the concentration of potassium was increased to 5, 60, and 140 mM KCl, the amplitudes of inward rectifying currents were elevated (5 mM, Ϫ83.1 Ϯ 9.5 pA; 60 mM, Ϫ226.6 Ϯ 17.1 pA; 140 mM, Ϫ500.0 Ϯ 30.4 pA at Ϫ140 mV) (Fig. 2F) . These data suggested that inwardly rectifying K ϩ currents exist in EPCs and the properties of these inwardly rectifying currents are similar to those of Kir.
The (1, 10 , and 100 M) inhibited inwardly rectifying currents in a dose-dependent fashion (1 M, 26.2 Ϯ 4.1%; 10 M, 88.5 Ϯ 4%; 100 M, 91.2 Ϯ 1.4% at Ϫ140 mV, respectively) and the pattern of Ba 2ϩ blockage was similar to that of Ba 2ϩ blockage reported in other cells (Fig. 3, A and B) (7, 51) . In addition to Ba 2ϩ , the application of extracellular Cs ϩ (10, 100, and 1,000 M) also inhibited inwardly rectifying currents in a dose-dependent fashion (10 M, 53 Ϯ 3.7%; 100 M, 57.6 Ϯ 9.0%; 1,000 M, 76.1 Ϯ 6.9% at Ϫ140 mV, respectively), and the pattern of Cs ϩ blockage was also similar that were recorded using established protocol in 140 mM KCl with TEA (1 mM), glibenclamide (10 M), and niflumic acid (100 M). The capacitive current traces are truncated. B: I-V relationship plotted from average currents recorded using step pulses from Ϫ140 to ϩ60 mV during 400 -500 ms, respectively (n ϭ 17, 8, 5, and 4).
to that of Cs ϩ blockage reported in other cells (Fig. 4 , A and B) (7, 51) . Our data showed that inward rectifying K ϩ currents are dose-dependently inhibited by Kir blockers.
Change of the membrane potential by Kir in EPCs. Next, to elucidate how Kir influences the electrophysiological properties of EPCs, we assessed the changes of membrane potential caused by the blockage of Kir in EPCs. Since it was difficult to measure membrane potential of EPCs under current-clamp mode, we used the voltage-sensitive dye DiBAC 3 (8, 22, 36) to estimate the membrane potential. We hypothesized that the application of Ba 2ϩ may alter the membrane potential of EPCs. Many papers have reported that the blockage of Kir depolarizes the membrane potential and induces a change in calcium concentration (10) . Before conducting the experiment, we optimized the experimental conditions by changing the membrane potential. As shown in Fig. 5B, (Fig. 6A) , whereas the mRNA expression of Kir1.1 and Kir2.3 was not detected. To confirm expression at the protein level, we selected four representative subtypes (Kir2.1, Kir2.4, Kir3.1, and Kir6.2) among Kir2.x, Kir3.x, and Kir6.x. Each subtype is known to be activated by membrane hyperpolarization, triggered by the activation of G protein-coupled receptors, and modulated by intracellular ATP, respectively. Selected subtypes were detected by Western blotting in EPC lysates (Fig. 6B) . Moreover, to elucidate the distribution of Kir protein in EPCs, we chose a Kir2.1 antibody for immunostaining on EPCs. Figure 6C shows that Kir is widely localized in EPCs. As shown in concentrations. Many reports have established the capacity of tube formation on Matrigel as an experiment that can demonstrate the endothelial function of EPCs. After seeding EPCs on Matrigel and incubating for 16 -24 h, we counted the number of tubes and calculated the area of each tube, based on the following standards to count a complete tube: 1) intact and complete hedron and 2) hedron that consists of more than four cells. We observed that the application of Ba 2ϩ resulted in a numerical reduction of complete tubes formed by EPCs on Matrigel (1 M, 18.1 Ϯ 2.7; 10 M, 11.2 Ϯ 2.2, P Ͻ 0.01; n ϭ 4, respectively) (Fig. 7B) , whereas the area (mm 2 ) of complete tubes was not altered (1 M, 0.27 Ϯ 0.05; 10 M, 0.27 Ϯ 0.05, respectively) (Fig. 7C) . On the basis of our data, we suggest that Kir contributes to the endothelial function of EPCs.
Proliferative capacity through Kir and the relation of proliferation and Kir2.1 in EPCs. In addition to the endothelial functions of Kir, we attempted to determine how Kir regulates the cellular proliferation of EPCs. To assess the proliferative effect of Kir in EPCs, we seeded EPCs on six-well culture plates with EGM-2-MV containing 0, 1, and 10 M Ba 2ϩ followed by incubation at 37°C. After 3-5 days, we manually calculated the number of EPCs on a hemocytometer and analyzed the cell cycle progression of EPCs via FACS analysis. Our data demonstrated that the number of EPCs was dose-dependently elevated in EGM-2-MV containing Ba 2ϩ (1 M, 137.4 Ϯ 11.4%; 10 M, 157.9 Ϯ 17.4%, P Ͻ 0.01; n ϭ 15, respectively) (Fig. 8B) . Additionally, we observed that the percentage of EPCs in the S phase related to DNA synthesis among G 0 /G 1 , S, and G 2 /M phase was increased under Ba 2ϩ (10 M, 26.5 Ϯ 1.5%, P Ͻ 0.05; n ϭ 3) (Fig. 8C) . To reduce concerns for Ba 2ϩ specificity as Kir blocker and further elucidate the role of Kir2.1 and Kir2.4 in EPC proliferation, we treated siRNA transfection reagent with siRNA Kir2.1 and Kir2.4 on EPCs. After 18 -24 h, the effect of siRNA was determined by Western blotting. Figure 8D shows the decrease of Kir2.1 and Kir2.4 expression in EPCs, implying that the knockdown was successfully conducted. Our siRNA data proposed that the number of EPCs was elevated in the group treated with Kir2.1 siRNA (116.2 Ϯ 2.5%, P Ͻ 0.01; n ϭ 5) but was not changed in the group treated with Kir2.4 siRNA (100.4 Ϯ 2.0%; n ϭ 5). The change of proliferative capacity in EPCs under Ba 2ϩ blockage conditions and the knockdown system suggested that Kir is an essential channel for the regulation of the proliferative activity and replicative capacity of EPCs. Also, the fact that specific inhibition of Kir2.1 through siRNA induced the increase in the number of EPCs provides support that Ba 2ϩ blocked Kir under our experimental conditions.
DISCUSSION
In the present study, using electrophysiological techniques, we recorded whole cell currents and confirmed the existence of Kir in EPCs. It was not until 1997 that researchers began to make efforts to establish definitive markers for EPCs and to evaluate the beneficial effects of EPCs in vascular disease models such as myocardial ischemia, cerebral atherosclerosis, and cerebral hemorrhage (9, 23) . For a number of years, although EPCs were used to investigate cell therapy and differentiation, direct information regarding the expression and functional role of ion channels in EPCs has not been well documented. Also, except for a report concerning functional Kir in porcine bone marrow progenitor cells (27) , there is no study on the expression and role of Kir in EPCs. Our results provide us not only with new information for establishing the characteristics of EPCs, but with a novel perspective about the relationship between expression of channels and functions in EPCs. This paper is the first to characterize the function of ion channels in EPCs from an electrophysiological point of view.
For this experiment, late EPCs, but not early EPCs, derived from human umbilical cord blood were examined because of the fact that late EPCs have been widely used from therapeutic research to clinical applications and in vitro culture systems , human ether-a-go-go-related gene 1 (hERG1), which has inwardly rectifying properties, and GAPDH as PCR control. The mRNA from human heart was commercially used as a positive control for each primer, and water (no template) was used as a negative control (n ϭ 4). B: protein expression of Kir2.1 (48 kDa), Kir2.4 (48 kDa), Kir3.1 (56 kDa), Kir6.2 (40 kDa), and GAPDH (38 kDa), detected using Western blotting (n ϭ 3). C: immunofluorescence images showing the wide distribution of Kir2.1 (green) and DAPI staining (blue) for nuclear labeling (n ϭ 3). Scale bar, 20 m.
have been well established with experiments in our laboratory (14, 15, 50) . The electrophysiological properties of EPCs were shown as two types of currents containing inwardly rectifying currents and outwardly rectifying currents, similar to those of human umbilical vein endothelial cells (HUVECs; 47), which implies that the distribution and expression of channels in EPCs may not be different from HUVECs. Also, several studies have reported that the molecular biological and physiological characteristics of EPCs are similar to those of endothelial cells (14, 15, 47) .
Generally, Kir has been well established as a key channel for the stability of membrane potential in cells. In particular, it was already reported that Kir maintains the RMP and is involved in the regulation of nitric oxide synthesis in endothelial cells (35) as well as the modulation of a host of signaling events. In our electrophysiology experiment, the amplitude of inwardly rectifying potassium currents in EPCs was increased depending on potassium concentration and extracellular application of submillimolar Ba 2ϩ and Cs ϩ inhibited inward rectifying potassium currents, both results of which made sure that Kir exists in EPCs. Also, the fact that Kir is related to the formation of membrane potential was validated by DiBAC 3 (voltage-sensitive dye), used as an alternative method for the visualization of the change in membrane potential. Using DiBAC 3 , we were able to record RMP by applying the calibration procedure based on the equilibrium potential of K ϩ and observe the relative elevation of membrane potential under Kir blockage by Ba 2ϩ . Although we did not fully exclude the possibility that Ba 2ϩ may affect other channels, when we recorded the whole cell currents with Ba 2ϩ , any direct effects on other channels were not detected. Recently, several reports concerning the relation of membrane potential and cellular functions have demonstrated that adipogenic and osteogenic differentiation is mediated by the change of membrane potential in mesenchymal stem cells (40) and that developmental and cancerous cells tend to be depolarized and mitotically active (41) . Moreover, lacking functional Kir displays active proliferation in response to injury (6) . These reports support our assumption that the change of membrane potential by Kir blockage in EPCs may be considered as underlying mechanisms in our functional assay.
Kir is composed principally of seven subfamilies. The Kir2 and 4 subfamilies, as strong inward rectifier potassium channels, which are known to be expressed abundantly in the heart, are sensitive to voltage, phosphorylation, and other second messengers (29, 32, 33) . Our RT-PCR data demonstrated that Kir2.1, 2.2, 2.4, and 4.1 are expressed in EPCs (Fig. 6A ) and the protein expression of Kir2.1 and Kir2.4 (Fig. 6B ) is detected using each antibody, thereby implying that the majority of inwardly rectifying K ϩ currents recorded in EPCs may pass through Kir2.1, 2.2, and 2.4. In addition to the Kir2 subfamily, mRNA and protein expression of the Kir3 and Kir6 subfamilies were determined in EPCs (Fig. 6, A and B) . The Kir3 subfamily is a G protein-activated strong inwardly rectifying K ϩ channel and is expressed in the heart, brain, and endocrine tissue (29) . Many reports have demonstrated that EPCs express G proteincoupled receptors, known to bind to ligands such as endothelium-1 and angiotensin II associated with EPC homing, differentiation, and proliferation (12, 16, 25, 30, 33, 37, 39) . We also found that EPCs express the Kir6 subfamily (K ATP ) (Fig. 6, A  and B) , which is regulated by intracellular ATP. Recently, there is increasing evidence that proliferation and invasion of EPCs are controlled by the increase of extracellular glucose level (5, 44, 52) . Finally, we evaluated the expression of hERG1, known as Kv11.1, which can pass inwardly rectifying currents.
Before the start of our functional study, we were still concerned about selectivity of Ba 2ϩ . However, although Ba 2ϩ has the likelihood to pass through nonselective cation channels or calcium channels as well as to affect other potassium channels, most researchers have used low concentration of Ba 2ϩ (10 M) as a Kir blocker in functional assays (26, 49) . Also, based on our data, in our siRNA experiment, it was determined that specific siRNA approach to knock down Kir2.1 and 2.4 may relieve concerns about the specificity of Ba 2ϩ . Generally, cell-to-cell networks have been shown to be indispensable for the differentiation of EPCs into endothelial cells, cell proliferation, and the operation of endothelial functions including the formation of vessels and the secretion of a variety of vascular growth factors. Our data showed that Ba 2ϩ induced a reduction in the number of tubes formed by EPCs on Matrigel, which indicates that Kir is an important channel for EPCs to form networks and interact with each other. Interestingly, we observed different results between number and area of tubes perhaps because incomplete tubes were excluded from the total. Next, we evaluated changes in the proliferative capacity of EPCs under different Ba 2ϩ concentrations and conditions using siRNA to understand the manner in which Kir regulates the proliferation of EPCs. In contrast to a recent report that the blockage of calcium-activated K ϩ channels and volume-sensitive chloride channels results in the reduction of proliferation in mouse mesenchymal stem cells (43) , our results revealed that blockage of Kir by Ba 2ϩ increases the cell number and the percentage of S phase in relation to DNA synthesis and replication in EPCs (Fig. 8, B and C) . We believe that different proliferative roles of each channel are attributed to the diversity of fundamental functions and cellular responsibility of channels in cells. Finally, specific knockdown of Kir2.1, known to show voltage-dependent strong inward rectification, induced the increase of proliferation in EPCs. Although the increase of proliferative activity by siRNA2.1 was not as much as the increase of proliferation by Ba 2ϩ , these data implied that the membrane potential of EPCs treated with siRNA2.1 might be changed. However, the possibility that other subtypes of Kir would be also associated with the functions of EPCs still remains.
In conclusion, EPCs represent a novel candidate in regenerative vessel therapy and participate in postnatal vasculogenesis in a variety of physiological and disease conditions. In addition, under these conditions, several factors including VEGF, erythropoietin, and granulocyte-macrophage colony-stimulating factor regulate the number of EPCs in the circulation and trigger the endothelial function of EPCs in an injury site by binding to their respective receptors (2, 11, 48) . Eventually, these series of responses are mediated by the activation of ion channels or receptors on the membrane, responding to the change of electrical potential and ligands. Here, we show that EPCs exhibit several Kir subtypes such as Kir2.x, 3.x, and 6.x, which may be modulated by the electrical activity, several ligands such as cytokines, and intracellular ATP level. Our observation may provide a novel foundation to understand the role and cellular mechanisms of EPCs in pathogenesis. Furthermore, if we further investigate functions of other channels as well as Kir in EPCs and manipulate their functional effects in EPCs using pharmacological and genetic modification, EPCs can be used as a more efficient candidate as stem cell-based therapy for vascular disease patients.
